PFNA

If you drink tap water, eat seafood, or simply live in an industrialized country, your blood almost certainly carries traces of a synthetic chemical your body cannot break down. It leaves slowly, over years, so whatever you have absorbed tends to stay.

This is one of the so-called forever chemicals, and standard bloodwork never looks for it. A single reading reflects years of cumulative exposure rather than anything you ate this week, which is exactly why it is worth knowing your number and watching it over time.

What This Chemical Actually Is

PFNA (perfluorononanoic acid) belongs to a large family of industrial compounds called PFAS (per- and polyfluoroalkyl substances). Your body does not make it and cannot break it down. It is a manufactured pollutant that enters your body mainly through food and drinking water, then lingers in your blood and organs.

Because it resists breakdown, your level reflects exposure and buildup rather than the activity of one organ. In autopsy studies, blood levels tracked closely with concentrations in major organs such as the liver, which supports blood as a reasonable window into your overall body burden. It also crosses the placenta and appears in breast milk, so exposure is not limited to adults.

There are no standardized clinical cutpoints for this marker. It is used mainly in research and exposure monitoring, so a single value is best read as a starting point, not a diagnosis. That is also why getting a baseline now and tracking your own trend gives you useful personal data as the science matures.

Cholesterol and Blood Lipids

The most consistent human finding is that higher blood levels track with higher cholesterol. This shows up in adults, adolescents, and children, and it holds in both contaminated communities and general populations.

Sources: Diabetes Prevention Program Outcomes Study (Lin et al.); Paulsboro community study (Graber et al.); Fit Futures study (Averina et al.).

What this means for you: if your cholesterol is higher than your diet and genetics seem to explain, an environmental exposure like this one is a plausible contributor worth measuring. It will not replace a lipid panel, but it can add context to a number that otherwise looks unexplained.

Liver Enzymes and Fatty Liver

Higher levels are also linked to signs of liver stress. A meta-analysis of human studies found that higher levels were associated with higher ALT (alanine aminotransferase, an enzyme that rises when liver cells are injured), though the effect was smaller than for some other PFAS. A large Canadian survey found a similar positive link with GGT (gamma-glutamyl transferase, another liver enzyme).

In Korean adults, higher levels were associated with nonalcoholic fatty liver disease, a condition where fat builds up in the liver, with roughly 16% to 26% higher odds and evidence that excess body weight explained part of the link. Animal and laboratory studies point to the same organ, showing fat build-up that involves PPARα, a protein that normally helps liver cells burn fat but that this chemical can push toward fat storage through indirect knock-on effects.

Kidneys, Pregnancy, and Other Signals

Beyond lipids and liver, the evidence is thinner and less consistent, but several associations recur. In a Taiwanese cohort followed for a decade, higher levels tracked with higher eGFR (estimated glomerular filtration rate, a measure of how fast the kidneys filter blood), which those researchers read as possible early kidney strain rather than better kidney health. Other work, including a large Korean survey, found the opposite pattern, with higher levels tied to lower filtration and higher kidney-disease risk, so the kidney evidence is genuinely mixed.

In pregnancy, higher early-pregnancy levels were associated with small-for-gestational-age birth, with about 32% higher odds per doubling in one cohort, and prenatal exposure showed a modest link with autism-related traits in children. A nested study also linked higher pre-diagnosis levels to kidney cancer, and higher levels were tied to a blunted peak antibody response after SARS-CoV-2 infection, though not after vaccination.

Some of these findings can look backwards at first glance. Higher levels linked to higher eGFR sounds like better kidney function, and lower levels in women often reflect menstruation, childbirth, or higher body fat rather than anything protective. The resolution is that this is an exposure marker, not a good-number or bad-number test: a higher value signals more accumulated pollutant, and the same physiology that lowers the number (blood loss, transfer to a fetus, distribution into body fat) is not the same as clearing a health risk.

Why One Reading Is Not Enough

A single value has real limits. Within-person consistency over time is only modest, with repeat-measure agreement scores ranging from about 0.16 to 0.48 in midlife women and 0.03 to 0.59 in a pregnancy cohort, where 1.0 would mean perfect stability. That means one measurement can misclassify your longer-term exposure.

Tracking matters even more here because the chemical clears so slowly. Its half-life, the time for your body to eliminate half of it, is estimated at roughly 2.35 to 4.3 years depending on the study. After a contaminated water source was removed in one community, blood levels fell only about 12% after one year and 27% after two years; another community saw a 58% drop over six years. A baseline plus follow-up testing is the only way to see whether your level is rising, holding, or slowly coming down.

A practical rhythm: get a baseline, retest in 6 to 12 months if you have changed a known exposure source such as your drinking water, and then periodically after that. Because levels move over years rather than weeks, there is little value in frequent short-interval testing.

When Results Can Be Misleading

A few factors can shift a single reading without reflecting a real change in your exposure:

• Pregnancy and reproductive history: levels can fall roughly 15% to 21% from early to late pregnancy in some cohorts, and women who have given birth or who menstruate tend to have lower readings.
• Body composition: in women, higher body fat has been associated with lower blood levels, which can mask real exposure.
• Lab method and specimen: results from serum, plasma, and cord blood are not identical, and different labs use different detection limits and rules for handling very low values, so numbers are not always directly comparable across tests.

Making Sense of an Unexpected Result

If your level comes back higher than expected, the next step is a short workup, not panic. Pair it with a lipid panel, ALT and GGT for the liver, and an eGFR for kidney filtration, since those are the systems most consistently linked to this exposure. A full PFAS panel is also worth ordering, because this is only one member of a large family and the others often move differently.

Then look upstream at the source. Check whether your drinking water has been tested, review recurring dietary sources such as frequent seafood, and consider your workplace and neighborhood. An environmental health specialist or a clinician familiar with chemical exposures can help you decide whether the pattern of your results warrants action or simple monitoring. No treatment is established to strip this chemical from your blood; approaches such as cholesterol-binding drugs or blood donation have been explored only in limited research and are not proven, so removing ongoing sources remains the meaningful lever.